Agree with wait 100% guti.....thank you so much for your ability to constantly adding very valuable DD to this board!!!
Hi Johnny! Just wanted to give you a little shout-out!!! I "know you" from over at INO....I am a new investor here. VERY excited about NVIV.....they really seem to have a great chance of helping people!
Once AGAIN guti. you are tremendous source of information for this board. Thank you for your continuous ability to "sniff out" very valuable information
EXCELLENT post, as usual guti....extremely informative! Thanks for sharing!!!
Craig, this is just a proof of concept trial. ONCS is changing their platform from monotherapy to combination therapy. If they are successful, they will then do a combination trial with a PD-1 drug, probably Keytruda
Your "point" was about ONCS and safety issues. Answer this question.....Has ONCS had ANY safety issues at all in their trials?
Hi dirk...thanks...and same to you! Spend much more of my time at the Google Board. No "noise" over there...just good, informative discussions, like it should be. You should join us if you haven't already!
Hi samyo. I wasn't debating him. A debate is when 2 people discuss their opposing views. I was simply pointing out how clueless he is to the facts regarding ONCS' platform!
I know exactly what you said...and you need to understand the facts!! In all of ONCS' trials there have been ZERO safety issues! They are the first company to use electroporation with IL-12.....there was no one prior to them that "used this system". Now, what part of this do you not understand?????
Say what???? ONCS has only been in existence since 2011 and they have had ZERO, I repeat ZERO safety issues...so please get your facts straight!
Ha...it's been 3 hours since I posted this and not ONE response from a basher...no surprise, actually
Gee, I wonder why that is....because they can't find any!
Yeah, right. He's just like professional baseball players, always looking for the best deal and constantly jumping ship. I'm sure he cares more about that than saving lives...LOL
Good post Cameron! Now why would I well respected doctor, a leader in the field of immunology leave a big pharma company to join a start-up small biotech one. "Surely" it had to be for the money.....ha, I don't think so! He is a strong believer in the power of combo therapies AND in what ONCS has to offer as part of that!